What will the results of market research tell a business? This article highlights how information gained from market research can really help your business. What can you learn from having conducting effective market research? Know your customers Market research will help you better understand your customers in a number of ways including demographic information […]
Read More
Latest updates on treating plasma cell dyscrasias Meral Beksac, MD, Ankara University, Ankara, Turkey, shares the latest updates on the treatment of plasma cell dyscrasias, as presented at EBMT 2021. Dr Beksac outlines the discovery and utilization of novel biomarkers, such as translocation of (11;14), as well as new data from the Phase III ANDROMEDA […]
Read More
NHRC summons Mizoram Chief Secretary over ‘cancer’ cases in state New Delhi [India], March 27 (ANI): The National Human Rights Commission (NHRC) has issued conditional summons to the Chief Secretary of the Government of Mizoram to appear before the Commission on May 31 along with the requisite reports on steps taken by the State on […]
Read More
Randy Carver persevered through a heart attack, cancer, and a plane crash to succeed as a … Randy Carver. Randy Carver This story is available exclusively to Insider subscribers. Become an Insider and start reading now. Randy Carver has gone through multiple setbacks in life to prevail in the financial industry. Carver started trading silver […]
Read More
Biochimica et Biophysica Acta (BBA) – Reviews on Cancer | Vol 1875, Issue 2, In progress (April … select article Clusterin as modulator of carcinogenesis: A potential avenue for targeted cancer therapy https://doi.org/10.1016/j.bbcan.2020.188500 Review articleAbstract only Clusterin as modulator of carcinogenesis: A potential avenue for targeted cancer therapy Prakash Priyadarshi Praharaj, Srimanta Patra, Debasna Pritimanjari […]
Read More
FDA Approves Ide-Cel for Relapsed/Refractory Multiple Myeloma The FDA has approved idecabtagene vicleucel (ide-cel; formerly bb2121; Abecma) for the treatment of adult patients with relapsed or refractory multiple myeloma after 4 or more prior therapies, including an immunomodulatory drug (IMiD), a proteasome inhibitor (PI), and an anti-CD38 antibody.1 Ide-cel represents the first B-cell maturation antigen […]
Read More What’s the link between coffee and cancer? [unable to retrieve full-text content] Coffee's effect on cancer. The most recent evidence links coffee consumption with lowered risks of liver and endometrial cancers. This was recently …Published at Fri, 26 Mar 2021 17:03:45 +0000
Read More
Oncology Investors to Hear “Cancer Device Company of the Year” Immunicom Present at … CEO Amir Jafri will demonstrate how his FDA Breakthrough Device’s platform-based, subtractive therapy business model optimizes standard of care and shareholder value. Immunicom, Inc., a global biotechnology company pioneering novel “subtractive” immunotherapies, today announced CEO Amir Jafri will speak at MedInvest’s […]
Read More.gif)
CAR Macrophages Tackle Challenges in Solid Cancer Treatment The advent of chimeric antigen receptor T cell technology has revolutionized the treatment of blood, or “liquid,” cancers. But solid tumors have largely resisted this type of immunotherapy. To overcome this obstacle, some researchers have started adding CARs to immune cells other than T cells. On March […]
Read More A Phase III Study Comparing JNJ-68284528 CAR T-Cell Therapy with a Combination of Standard … Full Title A Phase 3 Randomized Study Comparing JNJ-68284528, a Chimeric Antigen Receptor T cell (CAR-T) Therapy Directed Against BCMA, vs Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Subjects with Relapsed and Lenalidomide-Refractory Multiple Myeloma […]
Read More